Efficacy trials suggest that extra-fine particle beclometasone dipropionate-formoterol (efBDP-FOR) is comparable to fluticasone propionate-salmeterol (FP-SAL) in preventing asthma exacerbations at a ...
Chiesi Limited, the UK affiliate of Italian healthcare company Chiesi Farmaceutici, has launched a new mobile app for adult patients with asthma or chronic obstructive pulmonary disease (COPD) to ...
Switching patients to a beclomethasone/formoterol inhaler can significantly boost asthma control and reduce costs, suggests a new study. The study found using a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback